StockMacro
Menu

Xylem

$94.66 -15% in 6 monthsMarket cap $21.7B

XYL on XNYS, Manufacturing, Xylem Inc, job postings

Measures activity, not value. Not investment advice.

Insiders bought $986K of stock and sold nothing while shares fell 31% in 12 months.

  • WatchQuarterly revenue fell 3.0% to $2.2B while 12-month profit rose 14%

Written by AI from the data on this page, 21 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $9 billion in revenue in 2025.

Industry
Pumps & pumping equipment (Manufacturing)
Employees
22,000
Website
xylem.com
Listed
NYSE, US
Last results
27 Oct 2026
Next results
expected around 9 Feb 2027 (an estimate: a year ago it reported on 10 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $2.2B, net income $291.0M.
Quarter to 31 Dec 2021: revenue $1.3B, net income $113.0MQuarter to 31 Dec 2021: revenue $1.3B, net income $113.0MQuarter to 31 Mar 2022: revenue $1.3B, net income $82.0MQuarter to 31 Mar 2022: revenue $1.3B, net income $82.0MQuarter to 30 Jun 2022: revenue $1.4B, net income $112.0MQuarter to 30 Jun 2022: revenue $1.4B, net income $112.0MQuarter to 30 Sep 2022: revenue $1.4B, net income $12.0MQuarter to 30 Sep 2022: revenue $1.4B, net income $12.0MQuarter to 31 Dec 2022: revenue $1.5B, net income $149.0MQuarter to 31 Dec 2022: revenue $1.5B, net income $149.0MQuarter to 31 Mar 2023: revenue $1.4B, net income $99.0MQuarter to 31 Mar 2023: revenue $1.4B, net income $99.0MQuarter to 30 Jun 2023: revenue $1.7B, net income $92.0MQuarter to 30 Jun 2023: revenue $1.7B, net income $92.0MQuarter to 30 Sep 2023: revenue $2.1B, net income $152.0MQuarter to 30 Sep 2023: revenue $2.1B, net income $152.0MQuarter to 31 Dec 2023: revenue $2.1B, net income $266.0MQuarter to 31 Dec 2023: revenue $2.1B, net income $266.0MQuarter to 31 Mar 2024: revenue $2.0B, net income $153.0MQuarter to 31 Mar 2024: revenue $2.0B, net income $153.0MQuarter to 30 Jun 2024: revenue $2.2B, net income $194.0MQuarter to 30 Jun 2024: revenue $2.2B, net income $194.0MQuarter to 30 Sep 2024: revenue $2.1B, net income $217.0MQuarter to 30 Sep 2024: revenue $2.1B, net income $217.0MQuarter to 31 Dec 2024: revenue $2.3B, net income $326.0MQuarter to 31 Dec 2024: revenue $2.3B, net income $326.0MQuarter to 31 Mar 2025: revenue $2.1B, net income $169.0MQuarter to 31 Mar 2025: revenue $2.1B, net income $169.0MQuarter to 30 Jun 2025: revenue $2.3B, net income $226.0MQuarter to 30 Jun 2025: revenue $2.3B, net income $226.0MQuarter to 30 Sep 2025: revenue $2.3B, net income $227.0MQuarter to 30 Sep 2025: revenue $2.3B, net income $227.0MQuarter to 31 Dec 2025: revenue $2.4B, net income $335.0MQuarter to 31 Dec 2025: revenue $2.4B, net income $335.0MQuarter to 31 Mar 2026: revenue $2.1B, net income $193.0MQuarter to 31 Mar 2026: revenue $2.1B, net income $193.0MQuarter to 30 Jun 2026: revenue $2.3B, net income $263.0MQuarter to 30 Jun 2026: revenue $2.3B, net income $263.0MQuarter to 30 Sep 2026: revenue $2.2B, net income $291.0MQuarter to 30 Sep 2026: revenue $2.2B, net income $291.0M
31 Dec 2021RevenueNet incometallest bar $2.4B30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$2.2B$291.0M
30 Jun 2026$2.3B$263.0M
31 Mar 2026$2.1B$193.0M
31 Dec 2025$2.4B$335.0M
30 Sep 2025$2.3B$227.0M
30 Jun 2025$2.3B$226.0M
31 Mar 2025$2.1B$169.0M
31 Dec 2024$2.3B$326.0M
30 Sep 2024$2.1B$217.0M
30 Jun 2024$2.2B$194.0M
31 Mar 2024$2.0B$153.0M
31 Dec 2023$2.1B$266.0M
30 Sep 2023$2.1B$152.0M
30 Jun 2023$1.7B$92.0M
31 Mar 2023$1.4B$99.0M
31 Dec 2022$1.5B$149.0M
30 Sep 2022$1.4B$12.0M
30 Jun 2022$1.4B$112.0M
31 Mar 2022$1.3B$82.0M
31 Dec 2021$1.3B$113.0M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $9.1B $8.9B
Revenue growthRevenue of the last 12 months compared with the 12 months before. +1.9% +5.4%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $1.1B $948.0M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $4.52 $3.88
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 39.8% 38.2% 37.9%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 15.1% 12.8% 15.1%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 11.9% 10.7% 10.2%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 10.1% 11.3%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $921.0M $925.0M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $708.0M $1.2B
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $3.5B $2.0B
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $2.8B $771.0M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.34 0.54
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $44.78
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 20.1 26.5
P/SPrice to sales: market cap divided by revenue of the last 12 months. 2.4 2.4
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 2.7 2.7
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 2.1 4.0
Dividend yieldDividends per share declared in the latest fiscal year divided by the share price. 1.7% 1.3%

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
XylemXYL (this company) $21.7B20.12.4+1.9%11.9%
ITTITT $17.9B42.93.5+36%8.1%
IDEXIEX $16.1B30.14.4+6.9%14.6%
GracoGGG $11.1B21.54.8+5.4%22.4%
FlowserveFLS $9.7B38.22.1+0.2%5.4%
Gorman-RuppGRC $1.7B22.92.3+6.5%10.2%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

+$986K

bought $986K, sold $0

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-0.2%

1,069 13F filers vs 1,071

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

94%

215.2M shares held by 13F filers (30 Sep 2026) of 229.3M outstanding (23 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

3.8%

8.7M shares sold short (30 Oct 2026) of 229.3M outstanding (23 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

2.1

8.7M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-16%

10.3M shares sold short in the report before, 8.7M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

29%

29% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 56%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

-3.0%

$2.2B vs $2.3B (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

+13%

$89.0M vs $79.0M (quarter ended 30 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

$12.4M

the 12 months before: $6.1M

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$360K

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

22

22 articles in the last 7 days; its usual week has 4 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

5.5×

22 articles in the last 7 days; its usual week has 4.

Price $94.66 on 20 Nov 2026, -31% over 12 months (12-month range $88.23 to $146.13)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders bought a net $625K in the last 12 months (the 12 months before: -$5.0M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 6 published in the last 12 months (none in the 12 months before).
Revenue per quarter. Revenue $2.2B in the latest quarter, -3.0% on a year earlier.
Capital spending per quarter. Capital spending $89.0M in the latest quarter, +13% on a year earlier.
Institutional holders (13F filers). 1,069 13F filers reported holding it in the latest 13F quarter, +3.5% on a year earlier.
Federal obligations. Federal obligations: $11.6M published in the last 12 months, +68% on the 12 months before.
Lobbying spend. Lobbying spend: $360K published in the last 12 months, -45% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
27 Oct 20268-K and other filingsDirector or officer change
8 Sep 20268-K and other filingsA major agreement ended
18 Aug 20268-K and other filingsDirector or officer change
13 Aug 20268-K and other filingsDirector or officer change
13 Aug 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
16 Jun 2026Sharp changeShort interest spike: short interest spike, 7.6M vs usual 3.1M (2026-05-29); 2.6x the same period a year earlier
2 Jun 2026Sharp changeShort interest spike: short interest spike, 8.0M vs usual 2.9M (2026-05-15); 3.1x the same period a year earlier
12 May 2026Sharp changeShort interest spike: short interest spike, 6.1M vs usual 2.9M (2026-04-30); 2.0x the same period a year earlier
28 Apr 2026Sharp changeShort interest spike: short interest spike, 5.3M vs usual 2.9M (2026-04-15); 1.8x the same period a year earlier
17 Mar 2026Sharp changeShort interest spike: short interest spike, 4.8M vs usual 2.9M (2026-02-27); 1.4x the same period a year earlier
30 Jan 20258-K and other filingsRestructuring costs announced
15 Jan 20258-K and other filingsDirector or officer change
15 Jan 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
19 Oct 2024Sharp changeLobbying on a new issue: lobbying on a new issue: MAN (2024-09-30)
15 Oct 20248-K and other filingsDirector or officer change
15 Oct 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
27 Jun 2024Lobbying filinglobbying engagement terminated (WHITMER & WORRALL, LLC)
5 Mar 2024Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 94.0M vs usual 53.5M (2023-12-31); 1.6x the same period a year earlier
5 Mar 2024Sharp changeQuarterly revenue change: quarterly revenue change, 2.1B vs usual 1.4B (2023-12-31); 1.5x the same period a year earlier
7 Nov 2023Sharp changeQuarterly revenue change: quarterly revenue change, 2.1B vs usual 1.3B (2023-09-30); 1.6x the same period a year earlier
5 Sep 20238-K and other filingsDirector or officer change
5 Sep 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
15 Aug 2023Sharp changeMany funds opening a new position: many funds opening a new position, 119 vs usual 62 (2023-06-30); 2.7x the same period a year earlier
25 Jul 2023Sharp changeLobbying spend jump: lobbying spend jump, 320K vs usual 70K (2023-06-30); 5.3x the same period a year earlier
24 Jul 2023Lobbying filinglobbying engagement terminated (CAPSTONE NATIONAL PARTNERS)
20 Jul 2023Lobbying filinglobbying engagement terminated (in-house)
12 Jul 2023Lobbying filingnew lobbying registration (WHITMER & WORRALL, LLC)
11 Jul 2023Lobbying filingnew lobbying registration (CAPSTONE NATIONAL PARTNERS)
11 Jul 2023Lobbying filinglobbying engagement terminated (WHITMER & WORRALL, LLC)
13 Jun 2023Sharp changeShort interest spike: short interest spike, 8.3M vs usual 3.8M (2023-05-31); 2.1x the same period a year earlier
30 May 2023Sharp changeShort interest spike: short interest spike, 15.4M vs usual 3.8M (2023-05-15); 3.5x the same period a year earlier
24 May 20238-K and other filingsDirector or officer change
24 May 20238-K and other filingsCompleted an acquisition or asset sale
16 May 2023Sharp changeShort interest spike: short interest spike, 13.8M vs usual 3.8M (2023-04-28); 2.9x the same period a year earlier
2 May 2023Sharp changeShort interest spike: short interest spike, 13.2M vs usual 3.8M (2023-04-14); 2.4x the same period a year earlier
18 Apr 2023Sharp changeShort interest spike: short interest spike, 12.2M vs usual 3.8M (2023-03-31); 2.2x the same period a year earlier
14 Apr 2023Lobbying filingnew lobbying registration (MEHLMAN CONSULTING, INC.)
28 Mar 2023Sharp changeShort interest spike: short interest spike, 12.0M vs usual 3.8M (2023-03-15); 2.8x the same period a year earlier
14 Mar 2023Sharp changeShort interest spike: short interest spike, 10.0M vs usual 3.8M (2023-02-28); 2.3x the same period a year earlier
1 Mar 20238-K and other filingsDirector or officer change
1 Mar 20238-K and other filingsA major agreement ended
28 Feb 2023Sharp changeShort interest spike: short interest spike, 10.2M vs usual 3.8M (2023-02-15); 2.4x the same period a year earlier
14 Feb 2023Sharp changeMany funds opening a new position: many funds opening a new position, 102 vs usual 59.50 (2022-12-31); 1.7x the same period a year earlier
14 Feb 2023Sharp changeShort interest spike: short interest spike, 8.0M vs usual 3.8M (2023-01-31); 2.0x the same period a year earlier
20 Dec 20228-K and other filingsDirector or officer change
20 Dec 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
12 May 20228-K and other filingsDirector or officer change
4 May 20228-K and other filingsDirector or officer change
3 May 2022Sharp changeShort interest spike: short interest spike, 5.4M vs usual 3.6M (2022-04-14); 1.7x the same period a year earlier
12 Apr 2022Sharp changeShort interest spike: short interest spike, 5.5M vs usual 3.6M (2022-03-31); 1.9x the same period a year earlier
1 Mar 2022Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 81.0M vs usual 45.5M (2021-12-31); 1.7x the same period a year earlier
3 Feb 20228-K and other filingsDirector or officer change
3 Feb 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Dec 2021: -$243K published
Month from 1 Jan 2022: -$120K published
Month from 1 Feb 2022: $23K published
Month from 1 Mar 2022: -$49K published
Month from 1 Apr 2022: -$352K published
Month from 1 May 2022: -$6K published
Month from 1 Jun 2022: -$697K published
Month from 1 Aug 2022: -$559K published
Month from 1 Sep 2022: -$1.5M published
Month from 1 Nov 2022: -$1.3M published
Month from 1 Feb 2023: -$223K published
Month from 1 Mar 2023: -$7.1M published
Month from 1 Jul 2023: -$11.1M published
Month from 1 Nov 2023: -$10.0M published
Month from 1 Dec 2023: -$213K published
Month from 1 Feb 2024: -$4.7M published
Month from 1 Mar 2024: -$3.9M published
Month from 1 Jun 2024: -$3.3M published
Month from 1 Sep 2024: -$352K published
Month from 1 Dec 2024: $48.1 published
Month from 1 Mar 2025: -$2.1M published
Month from 1 Aug 2025: -$948K published
Month from 1 Sep 2025: -$140K published
Month from 1 Nov 2025: -$1.8M published
Month from 1 May 2026: -$360K published
Month from 1 Oct 2026: $986K published
H-1B/E-3 applications certified
Quarter from 1 Apr 2024: 4 published
Quarter from 1 Jul 2024: 3 published
Quarter from 1 Oct 2026: 6 published
Revenue per quarter
Quarter ended 31 Dec 2021: $1.3B, -3.6% on a year earlier; public on 26 Feb 2022
Quarter ended 31 Mar 2022: $1.3B, +1.3% on a year earlier; public on 5 May 2022
Quarter ended 30 Jun 2022: $1.4B, +1.0% on a year earlier; public on 3 Aug 2022
Quarter ended 30 Sep 2022: $1.4B, +9.1% on a year earlier; public on 2 Nov 2022
Quarter ended 31 Dec 2022: $1.5B, +14% on a year earlier; public on 25 Feb 2023
Quarter ended 31 Mar 2023: $1.4B, +14% on a year earlier; public on 5 May 2023
Quarter ended 30 Jun 2023: $1.7B, +26% on a year earlier; public on 5 Aug 2023
Quarter ended 30 Sep 2023: $2.1B, +50% on a year earlier; public on 1 Nov 2023
Quarter ended 31 Dec 2023: $2.1B, +41% on a year earlier; public on 29 Feb 2024
Quarter ended 31 Mar 2024: $2.0B, +40% on a year earlier; public on 3 May 2024
Quarter ended 30 Jun 2024: $2.2B, +26% on a year earlier; public on 31 Jul 2024
Quarter ended 30 Sep 2024: $2.1B, +1.3% on a year earlier; public on 1 Nov 2024
Quarter ended 31 Dec 2024: $2.3B, +6.5% on a year earlier; public on 4 Mar 2025
Quarter ended 31 Mar 2025: $2.1B, +1.8% on a year earlier; public on 30 Apr 2025
Quarter ended 30 Jun 2025: $2.3B, +6.1% on a year earlier; public on 1 Aug 2025
Quarter ended 30 Sep 2025: $2.3B, +7.8% on a year earlier; public on 29 Oct 2025
Quarter ended 31 Dec 2025: $2.4B, +6.2% on a year earlier; public on 26 Feb 2026
Quarter ended 31 Mar 2026: $2.1B, +2.7% on a year earlier; public on 29 Apr 2026
Quarter ended 30 Jun 2026: $2.3B, +1.5% on a year earlier; public on 29 Jul 2026
Quarter ended 30 Sep 2026: $2.2B, -3.0% on a year earlier; public on 28 Oct 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $81.0M, +72% on a year earlier; public on 26 Feb 2022
Quarter ended 31 Mar 2022: $49.0M, +26% on a year earlier; public on 5 May 2022
Quarter ended 30 Jun 2022: $46.0M, +12% on a year earlier; public on 3 Aug 2022
Quarter ended 30 Sep 2022: $53.0M, +13% on a year earlier; public on 2 Nov 2022
Quarter ended 31 Dec 2022: $60.0M, -26% on a year earlier; public on 25 Feb 2023
Quarter ended 31 Mar 2023: $49.0M, 0% on a year earlier; public on 5 May 2023
Quarter ended 30 Jun 2023: $54.0M, +17% on a year earlier; public on 5 Aug 2023
Quarter ended 30 Sep 2023: $74.0M, +40% on a year earlier; public on 1 Nov 2023
Quarter ended 31 Dec 2023: $94.0M, +57% on a year earlier; public on 29 Feb 2024
Quarter ended 31 Mar 2024: $74.0M, +51% on a year earlier; public on 3 May 2024
Quarter ended 30 Jun 2024: $73.0M, +35% on a year earlier; public on 31 Jul 2024
Quarter ended 30 Sep 2024: $74.0M, 0% on a year earlier; public on 1 Nov 2024
Quarter ended 31 Dec 2024: $100.0M, +6.4% on a year earlier; public on 4 Mar 2025
Quarter ended 31 Mar 2025: $71.0M, -4.1% on a year earlier; public on 30 Apr 2025
Quarter ended 30 Jun 2025: $98.0M, +34% on a year earlier; public on 1 Aug 2025
Quarter ended 30 Sep 2025: $79.0M, +6.8% on a year earlier; public on 29 Oct 2025
Quarter ended 31 Dec 2025: $83.0M, -17% on a year earlier; public on 26 Feb 2026
Quarter ended 31 Mar 2026: $90.0M, +27% on a year earlier; public on 29 Apr 2026
Quarter ended 30 Jun 2026: $89.0M, -9.2% on a year earlier; public on 29 Jul 2026
Quarter ended 30 Sep 2026: $89.0M, +13% on a year earlier; public on 28 Oct 2026
Institutional holders (13F filers)
31 Dec 2021 report: 735; public on 14 Feb 2022
31 Mar 2022 report: 701; public on 16 May 2022
30 Jun 2022 report: 679; public on 15 Aug 2022
30 Sep 2022 report: 668; public on 14 Nov 2022
31 Dec 2022 report: 750; public on 14 Feb 2023
31 Mar 2023 report: 777; public on 15 May 2023
30 Jun 2023 report: 841; public on 14 Aug 2023
30 Sep 2023 report: 807; public on 14 Nov 2023
31 Dec 2023 report: 856; public on 14 Feb 2024
31 Mar 2024 report: 929; public on 15 May 2024
30 Jun 2024 report: 977; public on 14 Aug 2024
30 Sep 2024 report: 952; public on 14 Nov 2024
31 Dec 2024 report: 945; public on 14 Feb 2025
31 Mar 2025 report: 975; public on 15 May 2025
30 Jun 2025 report: 1,014; public on 14 Aug 2025
30 Sep 2025 report: 1,033; public on 14 Nov 2025
31 Dec 2025 report: 1,081; public on 17 Feb 2026
31 Mar 2026 report: 1,085; public on 15 May 2026
30 Jun 2026 report: 1,071; public on 14 Aug 2026
30 Sep 2026 report: 1,069; public on 16 Nov 2026
Federal obligations
Month from 1 Apr 2024: $22K published
Month from 1 May 2024: $19K published
Month from 1 Jun 2024: $36K published
Month from 1 Jul 2024: $211K published
Month from 1 Aug 2024: $62K published
Month from 1 Sep 2024: $57K published
Month from 1 Nov 2024: $327K published
Month from 1 Dec 2024: $1.0M published
Month from 1 Jan 2025: $84K published
Month from 1 Feb 2025: $87K published
Month from 1 Apr 2025: $37K published
Month from 1 May 2025: $399K published
Month from 1 Jun 2025: $234K published
Month from 1 Jul 2025: $2.2M published
Month from 1 Aug 2025: $834K published
Month from 1 Sep 2025: $481K published
Month from 1 Oct 2025: $741K published
Month from 1 Nov 2025: $774K published
Month from 1 Dec 2025: $1.9M published
Month from 1 Jan 2026: $798K published
Month from 1 Feb 2026: $905K published
Month from 1 Mar 2026: $845K published
Month from 1 Apr 2026: $849K published
Month from 1 May 2026: $1.0M published
Month from 1 Jun 2026: $830K published
Month from 1 Jul 2026: $1.7M published
Month from 1 Aug 2026: $328K published
Month from 1 Sep 2026: $1.9M published
Month from 1 Oct 2026: $471K published
Month from 1 Nov 2026: $36K published
Lobbying spend
Quarter from 1 Jan 2022: $100K published
Quarter from 1 Apr 2022: $80K published
Quarter from 1 Jul 2022: $60K published
Quarter from 1 Oct 2022: $60K published
Quarter from 1 Jan 2023: $90K published
Quarter from 1 Apr 2023: $130K published
Quarter from 1 Jul 2023: $320K published
Quarter from 1 Oct 2023: $180K published
Quarter from 1 Jan 2024: $180K published
Quarter from 1 Apr 2024: $160K published
Quarter from 1 Jul 2024: $210K published
Quarter from 1 Jan 2025: $230K published
Quarter from 1 Apr 2025: $230K published
Quarter from 1 Jul 2025: $90K published
Quarter from 1 Oct 2025: $110K published
Quarter from 1 Jan 2026: $110K published
Quarter from 1 Apr 2026: $70K published
Quarter from 1 Jul 2026: $90K published
Quarter from 1 Oct 2026: $90K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market buying (USD, Form 4) at $986K (29 Oct 2026), higher than 100% of its own history.
  • Short interest spike: had 8.0M shares sold short in the 15 May 2026 report, 3.1× the same report last year Public on 28 May 2026.
  • Insider net buying (open market): Insiders bought a net $625K in the last 12 months (the 12 months before: -$5.0M).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 6 published in the last 12 months (none in the 12 months before).

Latest records

The names and amounts behind the totals, newest first

Last 90 days: no sales; 1 purchase, $986K. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
29 Oct 2026D Christian KochDirectorBuy11,000$89.60$986KForm 4
8 May 2026Geri-Michelle McShaneSVP, CAOSellafter exercising options4,269$117.46$501KForm 4
4 May 2026Jerome A PeribereDirectorBuy1,210$116.61$141KForm 4
5 Nov 2025Victoria D HarkerDirectorSell1,700$148.14$252KForm 4
31 Oct 2025Claudia S ToussaintEVP, CPSOSell10,421$152.64$1.6MForm 4
5 Sep 2025Geri-Michelle McShaneVP, CAOSell1,000$139.96$140KForm 4
20 Aug 2025Lisa GlatchDirectorSell4,900$140.66$689KForm 4
5 Aug 2025Victoria D HarkerDirectorSell1,800$143.63$259KForm 4

1,069 institutions reported shares at the end of Q3 2026, 94% of the shares outstanding; 100 opened a position, 116 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.24.5M10.7%$2.5B-579K-2.3%
Vanguard Capital Management LLC15.3M6.66%$1.5B-251K-1.6%
Vanguard Portfolio Management LLC12.4M5.42%$1.3B-180K-1.4%
State Street Corp11.3M4.91%$1.1B-191K-1.7%
Invesco Ltd.9.4M4.12%$956.3M+4.3M+85%
Geode Capital Management, LLC6.3M2.75%$636.9M-33K-0.5%
Impax Asset Management Group plc4.7M2.06%$478.2M+254K+5.7%
Royal Bank of Canada4.6M2.02%$468.2M+19K+0.4%
Amundi4.6M2.00%$464.1M-522K-10%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC4.5M1.98%$460.1M+268K+6.3%

Company events

All 41 company events

In 12 months: 3 director or officer changes, 2 major agreements, 1 agreement ended. Results releases and routine reports are left out.

FiledWhat happenedSource
27 Oct 2026Director or officer change8-K
8 Sep 2026Signed a major agreement; A major agreement endedSame filing: took on new debt8-K
18 Aug 2026Director or officer change8-K
13 Aug 2026Director or officer change8-K
29 May 2026Signed a major agreementSame filing: took on new debt8-K
30 Jan 2025Restructuring costs announced8-K
15 Jan 2025Director or officer change8-K
15 Oct 2024Director or officer change8-K

Reported lobbying spend: $90K in Q3 2026, $90K in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
25 Jun 2024EndedWhitmer & Worrall, LLCfor XylemIssues related to PFAS contamination on certain military base installations. Issues related to the National Defense Authorization Act for Fiscal Year 2025.; Issues related to water reuse and Buy America issues. Issues related to the implementation of H.R. 3684, the Infrastructure Investment and Jobs Act (IIJA). Issues related to the implementation of H.R. 5376, the Inflation Reduction Act of 2022. Issues related to PFAS liability. Issues related to S. 1; Issues related to Fiscal Year 2025 appropriations bills.; Issues related to the implementation of H.R. 3684, the Infrastructure Investment and Jobs Act (IIJA). Issues related to PFAS treatment for contaminated water, water re-use, Buy America, and other water remediation issues.Defense, Environment, Budget, TransportationFiling
1 Oct 2023EndedEvoqua Water Technologiesits own lobbyistsNot statedFiling
1 Jul 2023NewWhitmer & Worrall, LLCfor XylemIssues related to PFAS treatment for contaminated water, water re-use, Buy America, and other water remediation issues.Environment, Defense, Budget, TransportationFiling
30 Jun 2023EndedCapstone National Partnersfor XylemPFASCAWFiling
30 Jun 2023EndedWhitmer & Worrall, LLCfor Evoqua Water TechnologiesIssues related to PFAS treatment for contaminated water, water re-use, Buy America, and other water remediation issues. Issues related to the implementation of H.R. 3684, the Infrastructure Investment and Jobs Act (IIJA). Issues related to the implementation of H.R. 5376, the Inflation Reduction Act; Issues related to PFAS contamination on certain military base installations. Issues related to H.R. 2670, the National Defense Authorization Act for Fiscal Year 2024.; Issues related to H.R. 4366, the Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024. Issues related to S. 2127, the Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024. Issues related to H.R. 4365, the Department of Defense Appro; Issues related to the implementation of H.R. 3684, the Infrastructure Investment and Jobs Act (IIJA). Issues related to PFAS treatment for contaminated water, water re-use, Buy America, and other water remediation issues.Environment, Defense, Budget, TransportationFiling
15 May 2023NewCapstone National Partnersfor XylemPFAS water treatmentEnvironmentFiling
1 Mar 2023NewMehlman Consulting, Inc.for Xylem, Inc.Implementation of the Infrastructure and Jobs Act - P.L. 117-58, including the securing of Build America Buy America waivers for manufactured products.TradeFiling
25 Jul 2021NewEvoqua Water Technologiesits own lobbyistsIssues related to coal ash regulations, PFAS treatment for contaminated water, and other water remediation issuesDefense, UTI, Energy, Budget, CHM, Environment, CAWFiling
Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

15 Aug 2023confirmed

Confirmed across sources Institutional holdings and Lobbying

Xylem (XYL): reported $320K of lobbying spend for the quarter ended 30 Jun 2023, 5.3× the same quarter last year, while it saw 119 13F filers open a new position in the quarter ended 30 Jun 2023, 2.7× the same quarter last year. Two unrelated kinds of activity within 21 days.

  • Lobbying: Lobbying spend jump, became public on 20 Jul 2023
  • Institutional holdings: Many funds opening a new position, became public on 14 Aug 2023
2021-06-30: $60K2021-09-30: $60K2021-12-31: $100K2022-03-31: $80K2022-06-30: $60K2022-09-30: $60K2022-12-31: $90K2023-03-31: $130K2023-06-30: $320K
The quarter ended 30 Jun 2023 against the 8 quarters before it. this quarterearliernormal: $70K
See the evidence (2 changes)

Lobbying: Lobbying spend jump became public on 20 Jul 2023

Xylem reported $320K of lobbying spend for the quarter ended 30 Jun 2023, 5.3× the same quarter last year.

This period
$320K (the quarter ended 30 Jun 2023)
Normal quarter (median of 8 earlier)
$70K
Typical spread (median absolute deviation)
$10K
How far from its usual level
+12.5
Same quarter last year
$60K
History used
5,021 days
2021-06-30: $60K2021-09-30: $60K2021-12-31: $100K2022-03-31: $80K2022-06-30: $60K2022-09-30: $60K2022-12-31: $90K2023-03-31: $130K2023-06-30: $320K
the quarter ended 30 Jun 20238 earlier quartersnormal: $70K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.

Check it at the source: Senate/House lobbying disclosures (LDA).

Institutional holdings: Many funds opening a new position became public on 14 Aug 2023

Xylem saw 119 13F filers open a new position in the quarter ended 30 Jun 2023, 2.7× the same quarter last year.

This period
119 (the quarter ended 30 Jun 2023)
Normal quarter (median of 8 earlier)
62
Typical spread (median absolute deviation)
10.5
How far from its usual level
+3.7
Same quarter last year
44
History used
3,560 days
2021-06-30: 652021-09-30: 542021-12-31: 592022-03-31: 492022-06-30: 442022-09-30: 672022-12-31: 1022023-03-31: 892023-06-30: 119
the quarter ended 30 Jun 20238 earlier quartersnormal: 62

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

14 Feb 2023confirmed

Confirmed across sources Institutional holdings and Short interest and volume

Xylem (XYL): saw 102 13F filers open a new position in the quarter ended 31 Dec 2022, 1.7× the same quarter last year, while it had 8.3M shares sold short in the 31 May 2023 report, 2.1× the same report last year. Two unrelated kinds of activity within 119 days.

  • Institutional holdings: Many funds opening a new position, became public on 14 Feb 2023
  • Short interest and volume: Short interest spike, became public on 10 Feb 2023
  • Short interest and volume: Short interest spike, became public on 28 Feb 2023
  • Short interest and volume: Short interest spike, became public on 10 Mar 2023
  • Short interest and volume: Short interest spike, became public on 25 Mar 2023
  • Short interest and volume: Short interest spike, became public on 13 Apr 2023
  • Short interest and volume: Short interest spike, became public on 26 Apr 2023
  • Short interest and volume: Short interest spike, became public on 10 May 2023
  • Short interest and volume: Short interest spike, became public on 25 May 2023
  • Short interest and volume: Short interest spike, became public on 10 Jun 2023
2020-12-31: 682021-03-31: 602021-06-30: 652021-09-30: 542021-12-31: 592022-03-31: 492022-06-30: 442022-09-30: 672022-12-31: 102
The quarter ended 31 Dec 2022 against the 8 quarters before it. this quarterearliernormal: 59.5
See the evidence (10 changes)

Institutional holdings: Many funds opening a new position became public on 14 Feb 2023

Xylem saw 102 13F filers open a new position in the quarter ended 31 Dec 2022, 1.7× the same quarter last year.

This period
102 (the quarter ended 31 Dec 2022)
Normal quarter (median of 8 earlier)
59.5
Typical spread (median absolute deviation)
6.5
How far from its usual level
+4.4
Same quarter last year
59
History used
3,379 days
2020-12-31: 682021-03-31: 602021-06-30: 652021-09-30: 542021-12-31: 592022-03-31: 492022-06-30: 442022-09-30: 672022-12-31: 102
the quarter ended 31 Dec 20228 earlier quartersnormal: 59.5

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Short interest and volume: Short interest spike became public on 10 Feb 2023

Xylem had 8.0M shares sold short in the 31 Jan 2023 report, 2.0× the same report last year.

This period
8.0M (the 31 Jan 2023 report)
Normal report (median of 24 earlier)
3.8M
Typical spread (median absolute deviation)
234K
How far from its usual level
+10.9
Same report last year
4.0M
History used
1,859 days
2022-01-31: 4.0M2022-02-15: 4.2M2022-02-28: 4.3M2022-03-15: 4.3M2022-03-31: 5.5M2022-04-14: 5.4M2022-04-29: 4.7M2022-05-13: 4.4M2022-05-31: 3.9M2022-06-15: 3.6M2022-06-30: 3.4M2022-07-15: 4.1M2022-07-29: 3.3M2022-08-15: 3.7M2022-08-31: 3.6M2022-09-15: 3.6M2022-09-30: 3.6M2022-10-14: 3.4M2022-10-31: 4.0M2022-11-15: 3.8M2022-11-30: 3.6M2022-12-15: 3.7M2022-12-30: 3.7M2023-01-13: 3.7M2023-01-31: 8.0M
the 31 Jan 2023 report24 earlier reportsnormal: 3.8M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 28 Feb 2023

Xylem had 10.2M shares sold short in the 15 Feb 2023 report, 2.4× the same report last year.

This period
10.2M (the 15 Feb 2023 report)
Normal report (median of 24 earlier)
3.8M
Typical spread (median absolute deviation)
297K
How far from its usual level
+14.6
Same report last year
4.2M
History used
1,874 days
2022-02-15: 4.2M2022-02-28: 4.3M2022-03-15: 4.3M2022-03-31: 5.5M2022-04-14: 5.4M2022-04-29: 4.7M2022-05-13: 4.4M2022-05-31: 3.9M2022-06-15: 3.6M2022-06-30: 3.4M2022-07-15: 4.1M2022-07-29: 3.3M2022-08-15: 3.7M2022-08-31: 3.6M2022-09-15: 3.6M2022-09-30: 3.6M2022-10-14: 3.4M2022-10-31: 4.0M2022-11-15: 3.8M2022-11-30: 3.6M2022-12-15: 3.7M2022-12-30: 3.7M2023-01-13: 3.7M2023-01-31: 8.0M2023-02-15: 10.2M
the 15 Feb 2023 report24 earlier reportsnormal: 3.8M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Mar 2023

Xylem had 10.0M shares sold short in the 28 Feb 2023 report, 2.3× the same report last year.

This period
10.0M (the 28 Feb 2023 report)
Normal report (median of 24 earlier)
3.8M
Typical spread (median absolute deviation)
297K
How far from its usual level
+14.1
Same report last year
4.3M
History used
1,887 days
2022-02-28: 4.3M2022-03-15: 4.3M2022-03-31: 5.5M2022-04-14: 5.4M2022-04-29: 4.7M2022-05-13: 4.4M2022-05-31: 3.9M2022-06-15: 3.6M2022-06-30: 3.4M2022-07-15: 4.1M2022-07-29: 3.3M2022-08-15: 3.7M2022-08-31: 3.6M2022-09-15: 3.6M2022-09-30: 3.6M2022-10-14: 3.4M2022-10-31: 4.0M2022-11-15: 3.8M2022-11-30: 3.6M2022-12-15: 3.7M2022-12-30: 3.7M2023-01-13: 3.7M2023-01-31: 8.0M2023-02-15: 10.2M2023-02-28: 10.0M
the 28 Feb 2023 report24 earlier reportsnormal: 3.8M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 25 Mar 2023

Xylem had 12.0M shares sold short in the 15 Mar 2023 report, 2.8× the same report last year.

This period
12.0M (the 15 Mar 2023 report)
Normal report (median of 24 earlier)
3.8M
Typical spread (median absolute deviation)
297K
How far from its usual level
+18.6
Same report last year
4.3M
History used
1,902 days
2022-03-15: 4.3M2022-03-31: 5.5M2022-04-14: 5.4M2022-04-29: 4.7M2022-05-13: 4.4M2022-05-31: 3.9M2022-06-15: 3.6M2022-06-30: 3.4M2022-07-15: 4.1M2022-07-29: 3.3M2022-08-15: 3.7M2022-08-31: 3.6M2022-09-15: 3.6M2022-09-30: 3.6M2022-10-14: 3.4M2022-10-31: 4.0M2022-11-15: 3.8M2022-11-30: 3.6M2022-12-15: 3.7M2022-12-30: 3.7M2023-01-13: 3.7M2023-01-31: 8.0M2023-02-15: 10.2M2023-02-28: 10.0M2023-03-15: 12.0M
the 15 Mar 2023 report24 earlier reportsnormal: 3.8M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 13 Apr 2023

Xylem had 12.2M shares sold short in the 31 Mar 2023 report, 2.2× the same report last year.

This period
12.2M (the 31 Mar 2023 report)
Normal report (median of 24 earlier)
3.8M
Typical spread (median absolute deviation)
297K
How far from its usual level
+19.1
Same report last year
5.5M
History used
1,918 days
2022-03-31: 5.5M2022-04-14: 5.4M2022-04-29: 4.7M2022-05-13: 4.4M2022-05-31: 3.9M2022-06-15: 3.6M2022-06-30: 3.4M2022-07-15: 4.1M2022-07-29: 3.3M2022-08-15: 3.7M2022-08-31: 3.6M2022-09-15: 3.6M2022-09-30: 3.6M2022-10-14: 3.4M2022-10-31: 4.0M2022-11-15: 3.8M2022-11-30: 3.6M2022-12-15: 3.7M2022-12-30: 3.7M2023-01-13: 3.7M2023-01-31: 8.0M2023-02-15: 10.2M2023-02-28: 10.0M2023-03-15: 12.0M2023-03-31: 12.2M
the 31 Mar 2023 report24 earlier reportsnormal: 3.8M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 26 Apr 2023

Xylem had 13.2M shares sold short in the 14 Apr 2023 report, 2.4× the same report last year.

This period
13.2M (the 14 Apr 2023 report)
Normal report (median of 24 earlier)
3.8M
Typical spread (median absolute deviation)
297K
How far from its usual level
+21.4
Same report last year
5.4M
History used
1,932 days
2022-04-14: 5.4M2022-04-29: 4.7M2022-05-13: 4.4M2022-05-31: 3.9M2022-06-15: 3.6M2022-06-30: 3.4M2022-07-15: 4.1M2022-07-29: 3.3M2022-08-15: 3.7M2022-08-31: 3.6M2022-09-15: 3.6M2022-09-30: 3.6M2022-10-14: 3.4M2022-10-31: 4.0M2022-11-15: 3.8M2022-11-30: 3.6M2022-12-15: 3.7M2022-12-30: 3.7M2023-01-13: 3.7M2023-01-31: 8.0M2023-02-15: 10.2M2023-02-28: 10.0M2023-03-15: 12.0M2023-03-31: 12.2M2023-04-14: 13.2M
the 14 Apr 2023 report24 earlier reportsnormal: 3.8M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 May 2023

Xylem had 13.8M shares sold short in the 28 Apr 2023 report, 2.9× the same report last year.

This period
13.8M (the 28 Apr 2023 report)
Normal report (median of 24 earlier)
3.8M
Typical spread (median absolute deviation)
297K
How far from its usual level
+22.7
Same report last year
4.7M
History used
1,946 days
2022-04-29: 4.7M2022-05-13: 4.4M2022-05-31: 3.9M2022-06-15: 3.6M2022-06-30: 3.4M2022-07-15: 4.1M2022-07-29: 3.3M2022-08-15: 3.7M2022-08-31: 3.6M2022-09-15: 3.6M2022-09-30: 3.6M2022-10-14: 3.4M2022-10-31: 4.0M2022-11-15: 3.8M2022-11-30: 3.6M2022-12-15: 3.7M2022-12-30: 3.7M2023-01-13: 3.7M2023-01-31: 8.0M2023-02-15: 10.2M2023-02-28: 10.0M2023-03-15: 12.0M2023-03-31: 12.2M2023-04-14: 13.2M2023-04-28: 13.8M
the 28 Apr 2023 report24 earlier reportsnormal: 3.8M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 25 May 2023

Xylem had 15.4M shares sold short in the 15 May 2023 report, 3.5× the same report last year.

This period
15.4M (the 15 May 2023 report)
Normal report (median of 24 earlier)
3.8M
Typical spread (median absolute deviation)
297K
How far from its usual level
+26.5
Same report last year
4.4M
History used
1,963 days
2022-05-13: 4.4M2022-05-31: 3.9M2022-06-15: 3.6M2022-06-30: 3.4M2022-07-15: 4.1M2022-07-29: 3.3M2022-08-15: 3.7M2022-08-31: 3.6M2022-09-15: 3.6M2022-09-30: 3.6M2022-10-14: 3.4M2022-10-31: 4.0M2022-11-15: 3.8M2022-11-30: 3.6M2022-12-15: 3.7M2022-12-30: 3.7M2023-01-13: 3.7M2023-01-31: 8.0M2023-02-15: 10.2M2023-02-28: 10.0M2023-03-15: 12.0M2023-03-31: 12.2M2023-04-14: 13.2M2023-04-28: 13.8M2023-05-15: 15.4M
the 15 May 2023 report24 earlier reportsnormal: 3.8M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Jun 2023

Xylem had 8.3M shares sold short in the 31 May 2023 report, 2.1× the same report last year.

This period
8.3M (the 31 May 2023 report)
Normal report (median of 24 earlier)
3.8M
Typical spread (median absolute deviation)
297K
How far from its usual level
+10.2
Same report last year
3.9M
History used
1,979 days
2022-05-31: 3.9M2022-06-15: 3.6M2022-06-30: 3.4M2022-07-15: 4.1M2022-07-29: 3.3M2022-08-15: 3.7M2022-08-31: 3.6M2022-09-15: 3.6M2022-09-30: 3.6M2022-10-14: 3.4M2022-10-31: 4.0M2022-11-15: 3.8M2022-11-30: 3.6M2022-12-15: 3.7M2022-12-30: 3.7M2023-01-13: 3.7M2023-01-31: 8.0M2023-02-15: 10.2M2023-02-28: 10.0M2023-03-15: 12.0M2023-03-31: 12.2M2023-04-14: 13.2M2023-04-28: 13.8M2023-05-15: 15.4M2023-05-31: 8.3M
the 31 May 2023 report24 earlier reportsnormal: 3.8M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 29 Oct 2026Insiders record

    KOCH D CHRISTIAN (director) bought 11,000 shares of XYL ($985,600)

  2. 27 Oct 2026Filings record

    Director or officer change

  3. 8 Sep 2026Filings record

    A major agreement ended

  4. 18 Aug 2026Filings record

    Director or officer change

  5. 13 Aug 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  6. 13 Aug 2026Filings record

    Director or officer change

  7. 10 Jun 2026Short interest and volume change

    had 7.6M shares sold short in the 29 May 2026 report, 2.6× the same report last year.

    Same report last year: 2.9M; its normal report is 3.1M.

    See the evidence
    This period
    7.6M (the 29 May 2026 report)
    Normal report (median of 24 earlier)
    3.1M
    Typical spread (median absolute deviation)
    737K
    How far from its usual level
    +4.2
    Same report last year
    2.9M
    History used
    3,073 days
    2025-05-30: 2.9M2025-06-13: 2.3M2025-06-30: 2.4M2025-07-15: 2.2M2025-07-31: 2.3M2025-08-15: 2.4M2025-08-29: 2.3M2025-09-15: 2.9M2025-09-30: 2.6M2025-10-15: 2.7M2025-10-31: 3.0M2025-11-14: 3.2M2025-11-28: 3.5M2025-12-15: 3.3M2025-12-31: 3.3M2026-01-15: 2.8M2026-01-30: 4.2M2026-02-13: 4.5M2026-02-27: 4.8M2026-03-13: 4.0M2026-03-31: 4.9M2026-04-15: 5.3M2026-04-30: 6.1M2026-05-15: 8.0M2026-05-29: 7.6M
    the 29 May 2026 report24 earlier reportsnormal: 3.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  8. 28 May 2026Short interest and volume change

    had 8.0M shares sold short in the 15 May 2026 report, 3.1× the same report last year.

    Same report last year: 2.6M; its normal report is 2.9M.

    See the evidence
    This period
    8.0M (the 15 May 2026 report)
    Normal report (median of 24 earlier)
    2.9M
    Typical spread (median absolute deviation)
    551K
    How far from its usual level
    +6.2
    Same report last year
    2.6M
    History used
    3,059 days
    2025-05-15: 2.6M2025-05-30: 2.9M2025-06-13: 2.3M2025-06-30: 2.4M2025-07-15: 2.2M2025-07-31: 2.3M2025-08-15: 2.4M2025-08-29: 2.3M2025-09-15: 2.9M2025-09-30: 2.6M2025-10-15: 2.7M2025-10-31: 3.0M2025-11-14: 3.2M2025-11-28: 3.5M2025-12-15: 3.3M2025-12-31: 3.3M2026-01-15: 2.8M2026-01-30: 4.2M2026-02-13: 4.5M2026-02-27: 4.8M2026-03-13: 4.0M2026-03-31: 4.9M2026-04-15: 5.3M2026-04-30: 6.1M2026-05-15: 8.0M
    the 15 May 2026 report24 earlier reportsnormal: 2.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  9. 12 May 2026Short interest and volume change

    had 6.1M shares sold short in the 30 Apr 2026 report, 2.0× the same report last year.

    Same report last year: 3.1M; its normal report is 2.9M.

    See the evidence
    This period
    6.1M (the 30 Apr 2026 report)
    Normal report (median of 24 earlier)
    2.9M
    Typical spread (median absolute deviation)
    509K
    How far from its usual level
    +4.2
    Same report last year
    3.1M
    History used
    3,044 days
    2025-04-30: 3.1M2025-05-15: 2.6M2025-05-30: 2.9M2025-06-13: 2.3M2025-06-30: 2.4M2025-07-15: 2.2M2025-07-31: 2.3M2025-08-15: 2.4M2025-08-29: 2.3M2025-09-15: 2.9M2025-09-30: 2.6M2025-10-15: 2.7M2025-10-31: 3.0M2025-11-14: 3.2M2025-11-28: 3.5M2025-12-15: 3.3M2025-12-31: 3.3M2026-01-15: 2.8M2026-01-30: 4.2M2026-02-13: 4.5M2026-02-27: 4.8M2026-03-13: 4.0M2026-03-31: 4.9M2026-04-15: 5.3M2026-04-30: 6.1M
    the 30 Apr 2026 report24 earlier reportsnormal: 2.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  10. 5 May 2026Insiders record

    Peribere Jerome A (director) bought 1,210 shares of XYL ($141,098) (dated 4 May 2026)

  11. 25 Apr 2026Short interest and volume change

    had 5.3M shares sold short in the 15 Apr 2026 report, 1.8× the same report last year.

    Same report last year: 3.0M; its normal report is 2.9M.

    See the evidence
    This period
    5.3M (the 15 Apr 2026 report)
    Normal report (median of 24 earlier)
    2.9M
    Typical spread (median absolute deviation)
    438K
    How far from its usual level
    +3.6
    Same report last year
    3.0M
    History used
    3,029 days
    2025-04-15: 3.0M2025-04-30: 3.1M2025-05-15: 2.6M2025-05-30: 2.9M2025-06-13: 2.3M2025-06-30: 2.4M2025-07-15: 2.2M2025-07-31: 2.3M2025-08-15: 2.4M2025-08-29: 2.3M2025-09-15: 2.9M2025-09-30: 2.6M2025-10-15: 2.7M2025-10-31: 3.0M2025-11-14: 3.2M2025-11-28: 3.5M2025-12-15: 3.3M2025-12-31: 3.3M2026-01-15: 2.8M2026-01-30: 4.2M2026-02-13: 4.5M2026-02-27: 4.8M2026-03-13: 4.0M2026-03-31: 4.9M2026-04-15: 5.3M
    the 15 Apr 2026 report24 earlier reportsnormal: 2.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  12. 11 Mar 2026Short interest and volume change

    had 4.8M shares sold short in the 27 Feb 2026 report, 1.4× the same report last year.

    Same report last year: 3.4M; its normal report is 2.9M.

    See the evidence
    This period
    4.8M (the 27 Feb 2026 report)
    Normal report (median of 24 earlier)
    2.9M
    Typical spread (median absolute deviation)
    362K
    How far from its usual level
    +3.5
    Same report last year
    3.4M
    History used
    2,982 days
    2025-02-28: 3.4M2025-03-14: 3.0M2025-03-31: 3.4M2025-04-15: 3.0M2025-04-30: 3.1M2025-05-15: 2.6M2025-05-30: 2.9M2025-06-13: 2.3M2025-06-30: 2.4M2025-07-15: 2.2M2025-07-31: 2.3M2025-08-15: 2.4M2025-08-29: 2.3M2025-09-15: 2.9M2025-09-30: 2.6M2025-10-15: 2.7M2025-10-31: 3.0M2025-11-14: 3.2M2025-11-28: 3.5M2025-12-15: 3.3M2025-12-31: 3.3M2026-01-15: 2.8M2026-01-30: 4.2M2026-02-13: 4.5M2026-02-27: 4.8M
    the 27 Feb 2026 report24 earlier reportsnormal: 2.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  13. 30 Jan 2025Filings record

    Restructuring costs announced

  14. 15 Jan 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  15. 15 Jan 2025Filings record

    Director or officer change

  16. 3 Dec 2024Insiders record

    Tretikov Lila (director) bought 4 shares of XYL ($528) (dated 2 Dec 2024)

  17. 19 Oct 2024Lobbying change

    lobbying on a new issue.

    See the evidence
    New
    ['MAN']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    12768848
  18. 15 Oct 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  19. 15 Oct 2024Filings record

    Director or officer change

  20. 27 Jun 2024Lobbying record

    XYLEM: lobbying engagement terminated (WHITMER & WORRALL, LLC) (dated 25 Jun 2024)

  21. 5 Mar 2024Financials change

    reported revenue of $2.1B for the quarter ended 31 Dec 2023, 1.5× the same quarter last year.

    Same quarter last year: $1.4B; its normal quarter is $1.4B.

    See the evidence
    This period
    $2.1B (the quarter ended 31 Dec 2023)
    Normal quarter (median of 8 earlier)
    $1.4B
    Typical spread (median absolute deviation)
    $85.0M
    How far from its usual level
    +5.7
    Same quarter last year
    $1.4B
    History used
    4,840 days
    2021-12-31: $1.3B2022-03-31: $1.2B2022-06-30: $1.3B2022-09-30: $1.3B2022-12-31: $1.4B2023-03-31: $1.4B2023-06-30: $1.6B2023-09-30: $2.1B2023-12-31: $2.1B
    the quarter ended 31 Dec 20238 earlier quartersnormal: $1.4B

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  22. 5 Mar 2024Financials change

    spent $94.0M on capital projects in the quarter ended 31 Dec 2023, 1.6× the same quarter last year.

    Same quarter last year: $60.0M; its normal quarter is $53.5M.

    See the evidence
    This period
    $94.0M (the quarter ended 31 Dec 2023)
    Normal quarter (median of 8 earlier)
    $53.5M
    Typical spread (median absolute deviation)
    $5.5M
    How far from its usual level
    +5.0
    Same quarter last year
    $60.0M
    History used
    4,748 days
    2021-12-31: $81.0M2022-03-31: $49.0M2022-06-30: $46.0M2022-09-30: $53.0M2022-12-31: $60.0M2023-03-31: $49.0M2023-06-30: $54.0M2023-09-30: $74.0M2023-12-31: $94.0M
    the quarter ended 31 Dec 20238 earlier quartersnormal: $53.5M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  23. 7 Nov 2023Financials change

    reported revenue of $2.1B for the quarter ended 30 Sep 2023, 1.6× the same quarter last year.

    Same quarter last year: $1.3B; its normal quarter is $1.3B.

    See the evidence
    This period
    $2.1B (the quarter ended 30 Sep 2023)
    Normal quarter (median of 8 earlier)
    $1.3B
    Typical spread (median absolute deviation)
    $80.5M
    How far from its usual level
    +5.8
    Same quarter last year
    $1.3B
    History used
    4,748 days
    2021-09-30: $1.2B2021-12-31: $1.3B2022-03-31: $1.2B2022-06-30: $1.3B2022-09-30: $1.3B2022-12-31: $1.4B2023-03-31: $1.4B2023-06-30: $1.6B2023-09-30: $2.1B
    the quarter ended 30 Sep 20238 earlier quartersnormal: $1.3B

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  24. 5 Sep 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  25. 5 Sep 2023Filings record

    Director or officer change

  26. 15 Aug 2023several at once

    reported $320K of lobbying spend for the quarter ended 30 Jun 2023, 5.3× the same quarter last year, while it saw 119 13F filers open a new position in the quarter ended 30 Jun 2023, 2.7× the same quarter last year. Two unrelated kinds of activity within 21 days.

    See the evidence (2 changes)

    Lobbying: Lobbying spend jump became public on 20 Jul 2023

    Xylem reported $320K of lobbying spend for the quarter ended 30 Jun 2023, 5.3× the same quarter last year.

    This period
    $320K (the quarter ended 30 Jun 2023)
    Normal quarter (median of 8 earlier)
    $70K
    Typical spread (median absolute deviation)
    $10K
    How far from its usual level
    +12.5
    Same quarter last year
    $60K
    History used
    5,021 days
    2021-06-30: $60K2021-09-30: $60K2021-12-31: $100K2022-03-31: $80K2022-06-30: $60K2022-09-30: $60K2022-12-31: $90K2023-03-31: $130K2023-06-30: $320K
    the quarter ended 30 Jun 20238 earlier quartersnormal: $70K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.

    Check it at the source: Senate/House lobbying disclosures (LDA).

    Institutional holdings: Many funds opening a new position became public on 14 Aug 2023

    Xylem saw 119 13F filers open a new position in the quarter ended 30 Jun 2023, 2.7× the same quarter last year.

    This period
    119 (the quarter ended 30 Jun 2023)
    Normal quarter (median of 8 earlier)
    62
    Typical spread (median absolute deviation)
    10.5
    How far from its usual level
    +3.7
    Same quarter last year
    44
    History used
    3,560 days
    2021-06-30: 652021-09-30: 542021-12-31: 592022-03-31: 492022-06-30: 442022-09-30: 672022-12-31: 1022023-03-31: 892023-06-30: 119
    the quarter ended 30 Jun 20238 earlier quartersnormal: 62

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  27. 14 Aug 2023Institutional holdings change

    saw 119 13F filers open a new position in the quarter ended 30 Jun 2023, 2.7× the same quarter last year.

    Same quarter last year: 44; its normal quarter is 62.

    See the evidence
    This period
    119 (the quarter ended 30 Jun 2023)
    Normal quarter (median of 8 earlier)
    62
    Typical spread (median absolute deviation)
    10.5
    How far from its usual level
    +3.7
    Same quarter last year
    44
    History used
    3,560 days
    2021-06-30: 652021-09-30: 542021-12-31: 592022-03-31: 492022-06-30: 442022-09-30: 672022-12-31: 1022023-03-31: 892023-06-30: 119
    the quarter ended 30 Jun 20238 earlier quartersnormal: 62

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  28. 24 Jul 2023Lobbying record

    XYLEM: lobbying engagement terminated (CAPSTONE NATIONAL PARTNERS) (dated 30 Jun 2023)

  29. 20 Jul 2023Lobbying change

    reported $320K of lobbying spend for the quarter ended 30 Jun 2023, 5.3× the same quarter last year.

    Same quarter last year: $60K; its normal quarter is $70K.

    See the evidence
    This period
    $320K (the quarter ended 30 Jun 2023)
    Normal quarter (median of 8 earlier)
    $70K
    Typical spread (median absolute deviation)
    $10K
    How far from its usual level
    +12.5
    Same quarter last year
    $60K
    History used
    5,021 days
    2021-06-30: $60K2021-09-30: $60K2021-12-31: $100K2022-03-31: $80K2022-06-30: $60K2022-09-30: $60K2022-12-31: $90K2023-03-31: $130K2023-06-30: $320K
    the quarter ended 30 Jun 20238 earlier quartersnormal: $70K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.

    Check it at the source: Senate/House lobbying disclosures (LDA).

  30. 20 Jul 2023Lobbying record

    EVOQUA WATER TECHNOLOGIES: lobbying engagement terminated (in-house) (dated 1 Oct 2023)

  31. 12 Jul 2023Lobbying record

    XYLEM: new lobbying registration (WHITMER & WORRALL, LLC) (dated 1 Jul 2023)

  32. 11 Jul 2023Lobbying record

    XYLEM: new lobbying registration (CAPSTONE NATIONAL PARTNERS) (dated 15 May 2023)

  33. 11 Jul 2023Lobbying record

    EVOQUA WATER TECHNOLOGIES: lobbying engagement terminated (WHITMER & WORRALL, LLC) (dated 30 Jun 2023)

  34. 10 Jun 2023Short interest and volume change

    had 8.3M shares sold short in the 31 May 2023 report, 2.1× the same report last year.

    Same report last year: 3.9M; its normal report is 3.8M.

    See the evidence
    This period
    8.3M (the 31 May 2023 report)
    Normal report (median of 24 earlier)
    3.8M
    Typical spread (median absolute deviation)
    297K
    How far from its usual level
    +10.2
    Same report last year
    3.9M
    History used
    1,979 days
    2022-05-31: 3.9M2022-06-15: 3.6M2022-06-30: 3.4M2022-07-15: 4.1M2022-07-29: 3.3M2022-08-15: 3.7M2022-08-31: 3.6M2022-09-15: 3.6M2022-09-30: 3.6M2022-10-14: 3.4M2022-10-31: 4.0M2022-11-15: 3.8M2022-11-30: 3.6M2022-12-15: 3.7M2022-12-30: 3.7M2023-01-13: 3.7M2023-01-31: 8.0M2023-02-15: 10.2M2023-02-28: 10.0M2023-03-15: 12.0M2023-03-31: 12.2M2023-04-14: 13.2M2023-04-28: 13.8M2023-05-15: 15.4M2023-05-31: 8.3M
    the 31 May 2023 report24 earlier reportsnormal: 3.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  35. 25 May 2023Short interest and volume change

    had 15.4M shares sold short in the 15 May 2023 report, 3.5× the same report last year.

    Same report last year: 4.4M; its normal report is 3.8M.

    See the evidence
    This period
    15.4M (the 15 May 2023 report)
    Normal report (median of 24 earlier)
    3.8M
    Typical spread (median absolute deviation)
    297K
    How far from its usual level
    +26.5
    Same report last year
    4.4M
    History used
    1,963 days
    2022-05-13: 4.4M2022-05-31: 3.9M2022-06-15: 3.6M2022-06-30: 3.4M2022-07-15: 4.1M2022-07-29: 3.3M2022-08-15: 3.7M2022-08-31: 3.6M2022-09-15: 3.6M2022-09-30: 3.6M2022-10-14: 3.4M2022-10-31: 4.0M2022-11-15: 3.8M2022-11-30: 3.6M2022-12-15: 3.7M2022-12-30: 3.7M2023-01-13: 3.7M2023-01-31: 8.0M2023-02-15: 10.2M2023-02-28: 10.0M2023-03-15: 12.0M2023-03-31: 12.2M2023-04-14: 13.2M2023-04-28: 13.8M2023-05-15: 15.4M
    the 15 May 2023 report24 earlier reportsnormal: 3.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  36. 24 May 2023Filings record

    Director or officer change

  37. 24 May 2023Filings record

    Completed an acquisition or asset sale

  38. 10 May 2023Short interest and volume change

    had 13.8M shares sold short in the 28 Apr 2023 report, 2.9× the same report last year.

    Same report last year: 4.7M; its normal report is 3.8M.

    See the evidence
    This period
    13.8M (the 28 Apr 2023 report)
    Normal report (median of 24 earlier)
    3.8M
    Typical spread (median absolute deviation)
    297K
    How far from its usual level
    +22.7
    Same report last year
    4.7M
    History used
    1,946 days
    2022-04-29: 4.7M2022-05-13: 4.4M2022-05-31: 3.9M2022-06-15: 3.6M2022-06-30: 3.4M2022-07-15: 4.1M2022-07-29: 3.3M2022-08-15: 3.7M2022-08-31: 3.6M2022-09-15: 3.6M2022-09-30: 3.6M2022-10-14: 3.4M2022-10-31: 4.0M2022-11-15: 3.8M2022-11-30: 3.6M2022-12-15: 3.7M2022-12-30: 3.7M2023-01-13: 3.7M2023-01-31: 8.0M2023-02-15: 10.2M2023-02-28: 10.0M2023-03-15: 12.0M2023-03-31: 12.2M2023-04-14: 13.2M2023-04-28: 13.8M
    the 28 Apr 2023 report24 earlier reportsnormal: 3.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  39. 26 Apr 2023Short interest and volume change

    had 13.2M shares sold short in the 14 Apr 2023 report, 2.4× the same report last year.

    Same report last year: 5.4M; its normal report is 3.8M.

    See the evidence
    This period
    13.2M (the 14 Apr 2023 report)
    Normal report (median of 24 earlier)
    3.8M
    Typical spread (median absolute deviation)
    297K
    How far from its usual level
    +21.4
    Same report last year
    5.4M
    History used
    1,932 days
    2022-04-14: 5.4M2022-04-29: 4.7M2022-05-13: 4.4M2022-05-31: 3.9M2022-06-15: 3.6M2022-06-30: 3.4M2022-07-15: 4.1M2022-07-29: 3.3M2022-08-15: 3.7M2022-08-31: 3.6M2022-09-15: 3.6M2022-09-30: 3.6M2022-10-14: 3.4M2022-10-31: 4.0M2022-11-15: 3.8M2022-11-30: 3.6M2022-12-15: 3.7M2022-12-30: 3.7M2023-01-13: 3.7M2023-01-31: 8.0M2023-02-15: 10.2M2023-02-28: 10.0M2023-03-15: 12.0M2023-03-31: 12.2M2023-04-14: 13.2M
    the 14 Apr 2023 report24 earlier reportsnormal: 3.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  40. 14 Apr 2023Lobbying record

    XYLEM, INC.: new lobbying registration (MEHLMAN CONSULTING, INC.) (dated 1 Mar 2023)

Showing the newest 40 of 82 entries; narrow the window or the kind of data to see older ones.

Not listed: 281 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001524472
Ticker
XYL
Domain
xylem.com
Employer name
evoqua water technologies, XYLEM, INC., xylem services usa (2 unverified)
Hq location
DC|WASHINGTON|20003 (1 unverified)
Lobbying client
evoqua water technologies, xylem
Name
Aanderaa Data Instruments AS, Anadolu Flygt Pompa Pazarlama Ve Ticaret A.Ş, AYC Sinergia, S.L, Caribe Water Technology, Inc and 185 more
Uei
DUYCHQCPHTA7, JTK6KPLW2JP5, LFJVPJ77LNM7, UW56E24Z9B64
Wikidata
Q3146975
Wikipedia
Xylem Inc.
  • DOL H-1B labor condition applications and PERM certifications118 data points28 Oct 2019 to 21 Sep 2026
  • Federal lobbying disclosures (LDA)12 records, 215 data points1 Nov 2008 to 30 Sep 2026
  • SEC Form 13F institutional holdings1 record, 481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)148 records4 Feb 2016 to 13 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1259 data points31 Dec 2008 to 23 Oct 2026
  • SEC Form 4 insider transactions165 records, 548 data points3 Mar 2016 to 29 Oct 2026
  • FINRA short interest (twice monthly)627 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards975 data points12 Jul 2012 to 31 Oct 2026
  • Wikipedia pageviews2881 data points1 Jan 2019 to 20 Nov 2026